Root Financial Partners’s Fennec Pharmaceuticals FENC Stock Holding History

Root Financial Partners’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$575	Buy	+54	New	+$594	﹤0.01%	3176

Other funds holding FENC

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

PWMG

Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Root Financial Partners's FENC Position: Q3 2026 in Review

Root Financial Partners opened a new position in Fennec Pharmaceuticals (FENC) in Q3 2026: 54 shares worth $575. The stake represents ﹤0.01% of the portfolio and ranks #3176 among its holdings.

14 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

Root Financial Partners held 54 shares of Fennec Pharmaceuticals worth $575 as of Q3 2026.
Fennec Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
Fennec Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3176 holding.
14 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.